CRWV Form 4: McBee Brannin disposes of 625,000 Class A shares on 09/02/2025
Rhea-AI Filing Summary
CoreWeave insider sale summary: McBee Brannin, Chief Development Officer of CoreWeave (CRWV), reported multiple sales of Class A common stock executed on 09/02/2025 pursuant to a Rule 10b5-1 trading plan adopted on May 20, 2025. The reported transactions total 625,000 shares sold at weighted-average prices ranging across specified bands from about $90.75 up to $96.43 per share. After these transactions the reporting person directly beneficially owns 121,965 shares; additional shares are held indirectly in trusts, including 60,000 shares in the Canis Major SM Trust and 1,800 shares held of record by the reporting person’s minor child.
Positive
- Transactions executed under a Rule 10b5-1 plan, adopted May 20, 2025, which provides an affirmative defense for scheduled insider sales
- Complete disclosure of weighted-average price ranges and explanatory footnotes for the multiple sales
- Post-transaction holdings are reported, including direct holdings (121,965 shares) and trust allocations (e.g., 60,000 shares in Canis Major SM Trust)
Negative
- Material insider selling of 625,000 shares reported on a single date (09/02/2025), which represents significant insider liquidity
- Substantial reduction in directly held shares relative to earlier line items shown in the filing (reflected by remaining direct holding of 121,965 shares)
Insights
TL;DR: Insider executed a pre-planned program selling 625,000 shares on 09/02/2025; discloseable size but executed under a 10b5-1 plan.
The filing shows aggregate disposals of 625,000 Class A shares by McBee Brannin under a Rule 10b5-1 plan adopted May 20, 2025. Sales were reported at weighted-average prices within discrete price bands from roughly $90.75 to $96.43 per share. Post-transaction direct ownership is reported as 121,965 shares, with additional holdings in two trusts and a minor-child account. For investors, the filing is a clear disclosure of material insider liquidity but does not itself provide operational or financial performance information.
TL;DR: Multiple sales of material size executed through an established 10b5-1 plan; disclosure and plan adoption date are appropriate.
The Form 4 documents that the transactions were effected pursuant to a documented Rule 10b5-1 trading plan, which supports the affirmative defense for scheduled trading. The filer provided weighted-average price ranges and explanatory footnotes and identified indirect holdings by trusts and a minor child, including trustee relationships. The filing is procedurally complete and transparent regarding the mechanics and beneficiaries of the holdings disclosed.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Class A Common Stock | 28,735 | $91.3532 | $2.63M |
| Sale | Class A Common Stock | 104,694 | $92.3017 | $9.66M |
| Sale | Class A Common Stock | 40,167 | $93.2522 | $3.75M |
| Sale | Class A Common Stock | 30,661 | $94.2204 | $2.89M |
| Sale | Class A Common Stock | 32,761 | $95.2726 | $3.12M |
| Sale | Class A Common Stock | 11,102 | $96.032 | $1.07M |
| Sale | Class A Common Stock | 1,880 | $96.77 | $182K |
| Sale | Class A Common Stock | 43,103 | $91.3532 | $3.94M |
| Sale | Class A Common Stock | 157,040 | $92.3017 | $14.50M |
| Sale | Class A Common Stock | 60,250 | $93.2522 | $5.62M |
| Sale | Class A Common Stock | 45,992 | $94.2204 | $4.33M |
| Sale | Class A Common Stock | 49,141 | $95.2726 | $4.68M |
| Sale | Class A Common Stock | 16,654 | $96.032 | $1.60M |
| Sale | Class A Common Stock | 2,820 | $96.77 | $273K |
| holding | Class A Common Stock | -- | -- | -- |
| holding | Class A Common Stock | -- | -- | -- |
Footnotes (1)
- The reported transaction represents a sale effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 20, 2025. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $90.75 to $91.74, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote and in footnotes 3 through 7 of this Form 4. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $91.75 to $92.74, inclusive. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $92.75 to $93.74, inclusive. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $93.75 to $94.74, inclusive. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $94.76 to $95.75, inclusive. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $95.76 to $96.43, inclusive. The reported securities are directly held by the Brannin J. McBee 2022 Irrevocable Trust, of which the reporting person's spouse and minor child are beneficiaries and for which the reporting person's spouse serves as trustee. The reported securities are directly held by the Canis Major SM Trust (the "Canis Trust"), an irrevocable trust with a third-party trustee, of which the reporting person's minor child is beneficiary. The reporting person has the power to remove and replace the Canis Trust's trustee. The reported securities are directly held of record by the reporting person's minor child.